EVOLVING THE VISION FOR CANCER IMMUNOTHERAPY

Approach to Development

By building on cancer immunity cycle and immune phenotype research, Roche is advancing a more comprehensive vision for cancer immunotherapy—and a rational approach to combinations that may expand the potential of cancer immunotherapy to more patients.1,2

 
References 
  1. Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321-330. PMID: 28102259
  2. Kim JM, Chen DS. Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure). Ann Oncol. 2016;27:1492-1504. PMID: 27207108

For offline use follow these steps

By accessing this website from your mobile or tablet, you will be able to download its content for offline use.

  • iOS
  • Android
iOS

1. Access the website from your tablet or mobile using Safari as the browser. Make sure you aren’t in a private navigation window. 
2. Click on () on your browser window
3. Select “Add to Home Screen”

Android

1. Access the website from tablet or mobile using Chrome as the browser. Make sure you aren't in a private navigation window. 
2. Click on the menu icon ( ). 
3. Select "Add to homescreen"